This site is intended for UK healthcare professionals only

AstraZeneca has provided sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia.

Chronic Conditions Month 2024

Respiratory On-demand

Transforming COPD Care: What will it take

Presenters: Dinesh Shrikrishna, Taunton and Somerset NHS Foundation Trust

Chris Gale, Professor of Cardiovascular Medicine, Consultant Cardiologist

This is an educational, promotional video funded and created by AstraZeneca intended for GB HCPs.

AstraZeneca has provided a sponsorship towards this independent Programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations

Prescribing information for TRIXEO AEROSPHERE (formoterol fumarate dihydrate / glycopyrronium bromide / budesonide) click here

Prescribing information for BEVESPI AEROSPHERE (glycopyrronium bromide / formoterol fumarate dihydrate) click here

Prescribing information for SYMBICORT® (budesonide / formoterol fumarate dihydrate) click here

Prescribing information for DAXAS▼ (roflumilast) click here

 

Adverse events should be reported.  Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store.

Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033

If you have any questions, comments or queries or would like to request an appointment with an AstraZeneca representative, you can do so here

Therapy webcast sponsor

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca operates in over 100 countries and its medicines are used by millions of patients worldwide.

With a proud 100-year heritage in advancing UK science, today AstraZeneca is the UK’s leading biopharmaceutical company. AstraZeneca is based in six different locations across the UK, with its global headquarters in Cambridge. In the UK, around 8,600 employees work in research and development, manufacturing, supply, sales and marketing. We supply around 35 different medicines to the NHS.

GB-54030 | May 2024

For healthcare professionals only

Are you a healthcare professional?

The information is intended for healthcare professionals only.
Please confirm below.